Nachrichten zur Boston Scientific Corp. Aktie

Lessons From 2008 Crisis: Could Boston Scientific Stock Underperform Post Coronavirus-

While Boston Scientifics stock has declined due to the Coronavirus/Oil Price War crisis, going by trends seen during the 2008…

The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific and Abbott Laboratories

The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific and Abbott Laboratories...…

How Does Boston Scientific Get To $12 Billion Sales In 2020: Rhythm & Neuro Or Cardiovascular-

We estimate Boston Scientifics (NYSE: BSX) 2020 sales to be around $12 billion, driven by the companys cardiovascular segment. Boston…

Boston Scientific (BSX) Down 12.9% Since Last Earnings Report: Can It Rebound-

Boston Scientific (BSX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Why Boston Scientific Shares Fell 10.7% in February

Fewer elective surgery procedures in China may weigh on Boston Scientifics first-quarter earnings....…

TRUST WATCH: Worldwide Healthcare

Worldwide Healthcare invests in medical firms across the globe. Major holdings include Japans Takeda Pharmaceutical, medical devices firm Boston Scientific…

Boston Scientific Announces February and March 2020 Conference Schedule

MARLBOROUGH, Mass. , Feb 18, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate…

Is Boston Scientific Stock a Buy-

Boston Scientifics recent earnings report was mixed, but FDA clearance of a potentially blockbuster device could drive future revenue --…

Boston Scientific (BSX) Q4 2019 Earnings Call Transcript

BSX earnings call for the period ending December 31, 2019....…

Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

What to Like -- and Dislike -- About Boston Scientifics Q4 Results

The medical device maker posted mixed results in Q4. And the coronavirus outbreak is weighing on its 2020 Q1 outlook....…

Boston Scientific hemostatic clip patent dispute survives dismissal motion

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientific (BSX) Q4 Earnings Beat, Margins Decline

Boston Scientific (BSX) is steadily investing in new technologies as well as the global markets, reflecting its uptick in sales…

Boston Scientific slips 1% on Q4 results; issues downside guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientific profit buoyed by tax benefits

Boston Scientific Corp. BSX on Wednesday reported a rise in its fourth-quarter profit on the back of significant tax benefits,…

Boston Scientific Announces Results For Fourth Quarter And Full Year 2019

MARLBOROUGH, Mass. , Feb. 5, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales…

Boston Scientific EPS beats by $0.02, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientifics Q4 Earnings Preview: Can BSX Beat Average Consensus Earnings-

Boston Scientific (NYSE: BSX) is slated to release its Q4 and full-year 2019 results on February 5, 2020, and we…

Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

Boston Scientific (BSX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Can Solid IC Growth Aid Boston Scientific (BSX) Q4 Earnings-

Banking on an innovative portfolio across structural heart and coronary therapies, Boston Scientifics (BSX) IC business is expected to have…

Boston Scientific (BSX) Presents At NANS 2020 Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientific (BSX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientific Stock Dips on Dull Preliminary Q4 Results

Boston Scientifics (BSX) organic revenue growth will likely lag expectations for both the fourth quarter and 2019....…

Boston Scientific Shares Fall on Weak Preliminary Sales Numbers

Medical-device maker Boston Scientific reported preliminary fourth-quarter results that fell shy of Wall Streets expectations, sending shares down more than…

Boston Scientific down 6% on preliminary 2019 revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2019

MARLBOROUGH, Mass. , Jan. 14, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE:  BSX) generated sales,…

How Much Does Boston Scientific Spend On SG&A-

Boston Scientific (NYSE: BSX) spent $2.9 billion on selling, general & administrative (SG&A) expense in 2016, and the figure increased…

Healthy gains for Boston Scientific

A closer look at Boston Scientific's gains. With CNBC's Brian Sullivan and the Options Action traders, Carter Worth, Mike Khouw…

Herzklappen-Hersteller Symetis strebt an Schweizer Börse

Zürich (Reuters) - Die Medizintechnikfirma Symetis will sich mit Gang an die Schweizer Börse Geld für den Ausbau des Geschäfts…